Management and the Outcome of Liver Abscess, a Single Reference Experience in United Arab Emirates

Fatima Alharmoodi^1, , Noura Al-Ali², Arabella Hammoudeh¹ and Muhammed Badar Zaman³

¹Department of General Surgery, Tawam Hospital-Alain, United Arab Emirates

²Department of General Surgery, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates

³Department of General Surgery, Sheikh Khalifah Medical City, Abu Dhabi, United Arab Emirates

Cite this paper:
Fatima Alharmoodi, Noura Al-Ali, Arabella Hammoudeh and Muhammed Badar Zaman. Management and the Outcome of Liver Abscess, a Single Reference Experience in United Arab Emirates. Global Journal of Surgery. 2023; 11(1):5-8. doi: 10.12691/js-11-1-2

Abstract

Background: Pyogenic liver abscess is the most common form of liver abscess in the world. Early diagnosis and treatment can decrease its complications. Managing liver abscesses can be challenging. This study is directed on liver abscess management in a single center hospital. Methods: This is a retrospective review of all patients admitted to Sheikh Khalifah Medical City (SKMC) in United Arab Emirates with a diagnosis of liver abscess between January 2010 and November 2019 and the management that was offered to them. Results: Klebsiella Organism causes the majority of liver abscesses admitted at our center. We have found that a combined treatment modality using antibiotic and percutaneous drainage was the best approach. Conclusion: Liver abscesses are present among different nationalities affecting their health and life. Careful treatment should be obtained by a multimodal approach by using the right antibiotic and the assistance of interventional radiology.

Keywords:
liver abscess IR drainage antibiotic SKMC

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Mavilia, M., Molina, M., & Wu, G. (2016). The Evolving Nature of Hepatic Abscess: A Review. Journal of Clinical and Translational Hepatology.
[2]	Serraino, C., Elia, C., Bracco, C., Rinaldi, G., Pomero, F., Silvestri, A.,Fenoglio, L. M. (2018). Characteristics and management of pyogenic liver abscess. Medicine, 97(19).
[3]	Lübbert, C., Wiegand, J., & Karlas, T. (2014). Therapy of Liver Abscesses. Viszeralmedizin, 30(5), 3-3.
[4]	Sayek, I., & Onat, D. (2001). Pyogenic and amebic liver abscess. Surgical Treatment: Evidence-Based and Problem-Oriented.
[5]	Serraino, C., Elia, C., Bracco, C., Rinaldi, G., Pomero, F., Silvestri, A., … Fenoglio, L. M. (2018). Characteristics and management of pyogenic liver abscess. Medicine, 97(19).
[6]	Abbas, M. T., Khan, F. Y., Muhsin, S. A., Al-Dehwe, B., Abukamar, M., & Elzouki, A.-N. (2014). Epidemiology, Clinical Features and Outcome of Liver Abscess: A single Reference Center Experience in Qatar. Oman Medical Journal, 29(4), 260-263.
[7]	Albenmousa, A., Sanai, F. M., Singhal, A., Babatin, M. A., Alzanbagi, A. A., Al-Otaibi, M. M., … Bzeizi, K. I. (2011). Liver abscess presentation and management in Saudi Arabia and the United Kingdom. Annals of Saudi Medicine, 31(5), 528-532.
[8]	Neill, L., Edwards, F., Collin, S. M., Harrington, D., Wakerley, D., Rao, G. G., & Mcgregor, A. C. (2019). Clinical characteristics and treatment outcomes in a cohort of patients with pyogenic and amoebic liver abscess. BMC Infectious Diseases, 19(1).
[9]	Kao, W.-Y., Hwang, C.-Y., Chang, Y.-T., Su, C.-W., Hou, M.-C., Lin, H.-C., … Wu, J.-C. (2012). Cancer risk in patients with pyogenic liver abscess: a nationwide cohort study. Alimentary Pharmacology & Therapeutics, 36(5), 467-476.
[10]	Jayakar, S. R., & Nichkaode, P. B. (2018). Liver abscess, management strategies, and outcome. International Surgery Journal, 5(9), 3093.
[11]	Yoon, J. H., Kim, Y. J., & Kim, S. I. (2019). Prognosis of liver abscess with no identified organism. BMC Infectious Diseases, 19(1).
[12]	Czerwonko, M. E., Huespe, P., Bertone, S., Pellegrini, P., Mazza, O., Pekolj, J., … Santibañes, M. D. (2016). Pyogenic liver abscess: current status and predictive factors for recurrence and mortality of first episodes. Hpb, 18(12), 1023-1030.